Context Therapeutics (CNTX) Cash from Financing Activities (2020 - 2025)

Context Therapeutics (CNTX) posted Cash from Financing Activities of -$15268.0 for Q1 2025, down 100.11% sequentially from $14.5 million in Q4 2024.

Context Therapeutics (CNTX) Cash from Financing Activities (2020 - 2025) Analysis & Trends

Context Therapeutics has reported Cash from Financing Activities for 5 years, with the latest figure at -$15268.0 in Q1 2025.

Quarterly Cash from Financing Activities changed N/A year-over-year to -$15268.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was -$15268.0 (down 100.01% YoY) and the FY2025 annual result came in at -$15268.0, down 100.01% from the prior year.
Cash from Financing Activities eased to -$15268.0 in Q1 2025 per CNTX's latest filing, from $14.5 million in the prior quarter.
Over five years, Cash from Financing Activities peaked at $94.8 million in Q2 2024 and troughed at -$816917.0 in Q3 2021.
A 4-year average of $18.6 million and a median of $1.9 million in 2021 frame the typical range for Cash from Financing Activities.
The sharpest annual moves came in 2021 and 2022: Cash from Financing Activities jumped 15393.75% in 2021, then tumbled 103.36% in 2022.
Over 4 years, Cash from Financing Activities stood at $54.2 million in 2021, then plunged by 100.19% to -$102071.0 in 2022, then jumped by 14340.09% to $14.5 million in 2024, then slumped by 100.11% to -$15268.0 in 2025.
According to Business Quant data, Cash from Financing Activities over the past three periods registered -$15268.0, $14.5 million, and -$44632.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Financing Activities (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-426.70 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-1.22 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	14.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-6.05 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	36.24 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-16.65 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	27.18 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-273.15 Mn
10	Context Therapeutics	48.18 Mn	48.18 Mn	-	-

Download Data